Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Akdital's gross profit for the
six
months ended in Dec. 2025 was MAD485 Mil. Akdital's gross profit for the trailing twelve months (TTM) ended in Dec. 2025 was MAD2,155 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Akdital's gross profit for the
six
months ended in Dec. 2025 was MAD485 Mil. Akdital's Revenue for the
six
months ended in Dec. 2025 was MAD2,320 Mil. Therefore, Akdital's Gross Margin % for the quarter that ended in Dec. 2025 was 20.92%.
Akdital had a gross margin of 20.92% for the quarter that ended in Dec. 2025 => Competition eroding margins
During the past 7 years, the highestGross Margin % of Akdital was 57.58%. The lowest was 48.76%. And the median was 50.77%.
Warning Sign:
Akdital gross margin has been in long-term decline. The average rate of decline per year is -1.9%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Akdital had a gross margin of 20.92% for the quarter that ended in Dec. 2025 => Competition eroding margins
Akdital Gross Profit Related Terms
Akdital Gross Profit Historical Data
* Premium members only.
The historical data trend for Akdital's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Akdital's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akdital Gross Profit vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Akdital's Gross Profit distribution charts can be found below:
* The bar in red indicates where Akdital's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was MAD2,155 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Akdital (CAS:AKT) has a Gross Profit of MAD2,155 Mil as of Dec. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on Akdital and its competitors.
Is Akdital's Gross Profit too high?
Akdital's current Gross Profit is MAD2,155 Mil. Overall, Akdital has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Akdital's Gross Profit compare to HCA and THC?
Akdital's Gross Profit of MAD2,155 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Healthcare Providers & Services company?
A good Gross Profit depends on the Healthcare Providers & Services industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Akdital and its competitors. Akdital's current Gross Profit is MAD2,155 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akdital stock overvalued right now?
Based on GuruFocus' analysis, Akdital (CAS:AKT) is currently considered Possible Value Trap. The stock's GF Value™ is MAD1,741.54, compared to a current price of MAD1,145.00 — trading 34.3% below its estimated fair value. The current Gross Profit is MAD2,155 Mil. Akdital's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Akdital (CAS:AKT), the current Gross Profit is MAD2,155 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akdital (CAS:AKT) Overvalued in 2026?
Based on GuruFocus' analysis, Akdital stock appears to be undervalued.
The current stock price of MAD1,145.00 is trading 34.3% below its estimated GF Value™ of MAD1,741.54.
GuruFocus considers Akdital to be Possible Value Trap.
Key valuation signals for CAS:AKT:
Gross Profit: MAD2,155 Mil
GF Value™: MAD1,741.54 vs. price of MAD1,145.00 (34.3% below fair value)
No single metric tells the full story. See the CAS:AKT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
84GF Score
Get the complete analysis for CAS:AKT
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAS:AKT has been successfully added to your 
